143
Participants
Start Date
August 31, 2012
Primary Completion Date
April 30, 2014
Study Completion Date
August 31, 2014
lesinurad
Tablets, 400 mg QD
Grafton
Tauranga
Genk
Herston
Silverglen
Yvoir
Gozée
Hobart
Stellenbosch
Rondebosch
Kortrijk
New York
Brooklyn
New Windsor
Sellersville
Jenkintown
Landsdale
Richmond
Chesapeake
Suffold
Morgantown
Winston-Salem
Raleigh
Hickory
Spartanburg
Myrtle Beach
Newnan
Miami
Boynton Beach
Plant City
Tampa
Winter Haven
Birmingham
Birmingham
Birmingham
Brentwood
Spring Hill
Olive Branch
Jackson
Lexington
Elizabethtown
Perrysburg
Middleburg Heights
Cincinnati
Traverse City
Fargo
Metairie
Dallas
Houston
Englewood
Denver
Denver
Colorado Springs
Meridian
Bountiful
West Layton
Tempe
Glendale
Peoria
Albuquerque
Huntington Park
Covina
Irvine
Carmichael
Honolulu
Seattle
Spokane
Trumbill
Toronto
Québec
Rimouski
Dresden
Leipzig
Muckleneuk
Thabazimbi
Lead Sponsor
Ardea Biosciences, Inc.
INDUSTRY